Drs. Bell and DeVine dive into the literature and guidelines on what to do if a patient has adverse events or side effects with buprenorphine-naloxone (Suboxone). The guideline recommends transitioning to methadone, but what about transitioning to the monoproduct of buprenorphine (Subutex) instead? What’s the risk to the patient, the provider, or society? To learn more about the doctors as well as keep up with current happenings follow us on twitter: @echocsct or email us with questions or feedback: [email protected]

Learn more about your ad choices. Visit megaphone.fm/adchoices